{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:09:52Z","timestamp":1649160592365},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:00:00Z","timestamp":1400025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00120-014-3458-8","type":"journal-article","created":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T13:37:21Z","timestamp":1399901841000},"page":"890-892","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Studie zur Therapie beim nichtmuskelinvasiven Blasenkarzinom"],"prefix":"10.1007","volume":"53","author":[{"given":"H.","family":"Rexer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,14]]},"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-014-3458-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-014-3458-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-014-3458-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:04:28Z","timestamp":1558609468000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-014-3458-8"}},"subtitle":["Behandlung des nichtmuskelinvasiven High-grade-Urothelkarzinoms der Harnblase mit der Standardanzahl und Dosierung intravesikaler BCG-Instillationen vs. einer reduzierten Anzahl intravesikaler BCG-Instillationen in der Standarddosierung: eine randomisierte Phase-3-Studie der \u201eEuropean Association of Urology Research Foundation\u201c (NIMBUS \u2013 AB 37\/10 der AUO)"],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["3458"],"URL":"https:\/\/doi.org\/10.1007\/s00120-014-3458-8","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}